J.M. Foran
Imperial Cancer Research Fund Medical Oncology Unit
St Bartholomew's Hospital
London
United Kingdom
Name/email consistency: high
- European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. Foran, J.M., Rohatiner, A.Z., Cunningham, D., Popescu, R.A., Solal-Celigny, P., Ghielmini, M., Coiffier, B., Johnson, P.W., Gisselbrecht, C., Reyes, F., Radford, J.A., Bessell, E.M., Souleau, B., Benzohra, A., Lister, T.A. J. Clin. Oncol. (2000)
- Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): analysis of factors associated with response. Foran, J.M., Cunningham, D., Coiffier, B., Solal-Celigny, P., Reyes, F., Ghielmini, M., Johnson, P.W., Gisselbrecht, C., Bradburn, M., Matthews, J., Lister, T.A. Ann. Oncol. (2000)
- Pharmacokinetic study of single doses of oral fludarabine phosphate in patients with "low-grade" non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia. Foran, J.M., Oscier, D., Orchard, J., Johnson, S.A., Tighe, M., Cullen, M.H., de Takats, P.G., Kraus, C., Klein, M., Lister, T.A. J. Clin. Oncol. (1999)
- Monoclonal Epstein-Barr virus-related lymphoproliferative disorder following adult acute lymphoblastic leukaemia. Foran, J.M., Slater, S.E., Norton, A.J., Wilkes, S.J., Hart, I.J., Rohatiner, A.Z. Br. J. Haematol. (1999)